Bradley & Co Private Wealth Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.17K | Hold |
27
| – | – | 0.01% | 128 |
|
|
2025
Q1 | $8.94K | Hold |
27
| – | – | 0.01% | 125 |
|
|
2024
Q4 | $8.33K | Buy |
+27
| New | +$8.33K | 0.01% | 123 |
|
|
2024
Q2 | $30.8K | Hold |
110
| – | – | 0.02% | 82 |
|
|
2024
Q1 | $29.4K | Hold |
110
| – | – | 0.02% | 87 |
|
|
2023
Q4 | $25.5K | Hold |
110
| – | – | 0.02% | 88 |
|
|
2023
Q3 | $16.1K | Hold |
110
| – | – | 0.02% | 106 |
|
|
2023
Q2 | $25.4K | Hold |
110
| – | – | 0.03% | 85 |
|
|
2023
Q1 | $26.6K | Buy |
110
+83
| +307% | +$20.1K | 0.03% | 85 |
|
|
2022
Q4 | $7.84K | Hold |
27
| – | – | 0.01% | 121 |
|
|
2022
Q3 | $2K | Hold |
27
| – | – | ﹤0.01% | 169 |
|
|
2022
Q2 | $2K | Hold |
27
| – | – | ﹤0.01% | 173 |
|
|
2022
Q1 | $3K | Hold |
27
| – | – | ﹤0.01% | 140 |
|
|
2021
Q4 | $2K | Hold |
27
| – | – | ﹤0.01% | 150 |
|
|
2021
Q3 | $2K | Hold |
27
| – | – | ﹤0.01% | 151 |
|
|
2021
Q2 | $3K | Hold |
27
| – | – | ﹤0.01% | 154 |
|
|
2021
Q1 | $3K | Buy |
+27
| New | +$3K | ﹤0.01% | 156 |
|